John McDonagh

Former Commercial Executive within Johnson & Johnson; Former Global Head of One Touch Hospital Blood Glucose Monitoring Business; Former Head of TYLENOL Franchise at Johnson & Johnson

Mr. McDonagh has over 25 years of commercial healthcare leadership across consumer, medical device, and pharmaceutical business models. Mr. McDonagh was responsible for launching and growing key Johnson & Johnson brands such as TYLENOL, PEPCID AC and CONCERTA. Mr. McDonagh is the Chief Executive Officer of NextEvo and consults on ACT Labs’ commercial strategy.